메뉴 건너뛰기




Volumn 21, Issue , 2017, Pages S6-S20

Overview of iron metabolism in health and disease

Author keywords

anemia; chronic kidney disease; iron deficiency; Iron metabolism; iron overload

Indexed keywords

AMYLOID PRECURSOR PROTEIN; CD71 ANTIGEN; CERULOPLASMIN; FERRITIN; FERROPORTIN; FIBROBLAST GROWTH FACTOR 23; FRATAXIN; HEME OXYGENASE 1; HEMOGLOBIN; HEPHAESTIN; HYPOXIA INDUCIBLE FACTOR; IRON; IRON REGULATORY FACTOR; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; TRANSFERRIN; TRANSFERRIN RECEPTOR 2; UBIQUITIN;

EID: 85015193487     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/hdi.12542     Document Type: Review
Times cited : (351)

References (145)
  • 1
    • 0037471691 scopus 로고    scopus 로고
    • On the origins of cells: A hypothesis for the evolutionary transitions from abiotic geochemistry to chemoautotrophic prokaryotes, and from prokaryotes to nucleated cells
    • Martin W, Russell MJ. On the origins of cells: A hypothesis for the evolutionary transitions from abiotic geochemistry to chemoautotrophic prokaryotes, and from prokaryotes to nucleated cells. Philos Trans R Soc Lond, B, Biol Sci. 2003; 358:59–83.
    • (2003) Philos Trans R Soc Lond, B, Biol Sci. , vol.358 , pp. 59-83
    • Martin, W.1    Russell, M.J.2
  • 2
    • 84860574815 scopus 로고    scopus 로고
    • Iron sensing and signalling
    • Evstatiev R, Gasche C. Iron sensing and signalling. Gut. 2012; 61:933–952.
    • (2012) Gut. , vol.61 , pp. 933-952
    • Evstatiev, R.1    Gasche, C.2
  • 3
    • 84942357964 scopus 로고    scopus 로고
    • Pathogens, metabolic adaptation, and human diseases—An iron-thrifty genetic model
    • Pietrangelo A. Pathogens, metabolic adaptation, and human diseases—An iron-thrifty genetic model. Gastroenterology. 2015; 149:834–838.
    • (2015) Gastroenterology. , vol.149 , pp. 834-838
    • Pietrangelo, A.1
  • 4
    • 79954642381 scopus 로고    scopus 로고
    • Advances in metal-induced oxidative stress and human disease
    • Jomova K, Valko M. Advances in metal-induced oxidative stress and human disease. Toxicology. 2011; 283:65–87.
    • (2011) Toxicology. , vol.283 , pp. 65-87
    • Jomova, K.1    Valko, M.2
  • 5
    • 84885768132 scopus 로고    scopus 로고
    • Systemic iron homeostasis
    • Ganz T. Systemic iron homeostasis. Physiol Rev. 2013; 93:1721–1741.
    • (2013) Physiol Rev. , vol.93 , pp. 1721-1741
    • Ganz, T.1
  • 8
    • 0035793856 scopus 로고    scopus 로고
    • An iron-regulated ferric reductase associated with the absorption of dietary iron
    • McKie AT, Barrow D, Latunde-Dada GO, et al. An iron-regulated ferric reductase associated with the absorption of dietary iron. Science. 2001; 291:1755–1759.
    • (2001) Science. , vol.291 , pp. 1755-1759
    • McKie, A.T.1    Barrow, D.2    Latunde-Dada, G.O.3
  • 9
    • 0030763856 scopus 로고    scopus 로고
    • Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene
    • Fleming MD, Trenor CC, III, Su MA, et al. Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nat Genet. 1997; 16:383–386.
    • (1997) Nat Genet. , vol.16 , pp. 383-386
    • Fleming, M.D.1    Trenor, C.C.2    Su, M.A.3
  • 10
    • 0030755366 scopus 로고    scopus 로고
    • Cloning and characterization of. a mammalian proton-ion transporter
    • Gunshin H, Mackenzie B, Berger UV, et al. Cloning and characterization of. a mammalian proton-ion transporter. Nature. 1997; 388:482–488.
    • (1997) Nature. , vol.388 , pp. 482-488
    • Gunshin, H.1    Mackenzie, B.2    Berger, U.V.3
  • 11
    • 18244399587 scopus 로고    scopus 로고
    • Slc11a2 is required for intestinal iron absorption and erythropoiesis but dispensable in placenta and liver
    • Gunshin H, Fujiwara Y, Custodio AO, et al. Slc11a2 is required for intestinal iron absorption and erythropoiesis but dispensable in placenta and liver. J Clin Invest. 2005; 115:1258–1266.
    • (2005) J Clin Invest. , vol.115 , pp. 1258-1266
    • Gunshin, H.1    Fujiwara, Y.2    Custodio, A.O.3
  • 12
    • 84986216663 scopus 로고    scopus 로고
    • Intestinal brush-border Na+/H+ exchanger-3 drives H+-coupled iron absorption in the mouse
    • Shawki A, Engevik MA, Kim RS, et al. Intestinal brush-border Na+/H+ exchanger-3 drives H+-coupled iron absorption in the mouse. Am J Physiol Gastrointest Liver Physiol. 2016; 311:G423–G430.
    • (2016) Am J Physiol Gastrointest Liver Physiol. , vol.311 , pp. G423-G430
    • Shawki, A.1    Engevik, M.A.2    Kim, R.S.3
  • 13
    • 0014265208 scopus 로고
    • Absorption of hemoglobin iron: The role of a heme-splitting substance in the intestinal mucosa
    • Weintraub LR, Weinstein MB, Huser HJ, et al. Absorption of hemoglobin iron: The role of a heme-splitting substance in the intestinal mucosa. J Clin Invest. 1968; 47:531–539.
    • (1968) J Clin Invest. , vol.47 , pp. 531-539
    • Weintraub, L.R.1    Weinstein, M.B.2    Huser, H.J.3
  • 14
    • 84863229838 scopus 로고    scopus 로고
    • Absorption of iron from ferritin is independent of heme iron and ferrous salts in women and rat intestinal segments
    • Theil EC, Chen H, Miranda C, et al. Absorption of iron from ferritin is independent of heme iron and ferrous salts in women and rat intestinal segments. J Nutr. 2012; 142:478–483.
    • (2012) J Nutr. , vol.142 , pp. 478-483
    • Theil, E.C.1    Chen, H.2    Miranda, C.3
  • 15
    • 84945962756 scopus 로고    scopus 로고
    • The importance of eukaryotic ferritins in iron handling and cytoprotection
    • Arosio P, Carmona F, Gozzelino R, Maccarinelli F, Poli M. The importance of eukaryotic ferritins in iron handling and cytoprotection. Biochem J. 2015; 472:1–15.
    • (2015) Biochem J. , vol.472 , pp. 1-15
    • Arosio, P.1    Carmona, F.2    Gozzelino, R.3    Maccarinelli, F.4    Poli, M.5
  • 16
    • 77956327702 scopus 로고    scopus 로고
    • Intestinal ferritin H is required for an accurate control of iron absorption
    • Vanoaica L, Darshan D, Richman L, Schümann K, Kühn LC. Intestinal ferritin H is required for an accurate control of iron absorption. Cell Metab. 2010; 12:273–282.
    • (2010) Cell Metab. , vol.12 , pp. 273-282
    • Vanoaica, L.1    Darshan, D.2    Richman, L.3    Schümann, K.4    Kühn, L.C.5
  • 17
    • 0034677467 scopus 로고    scopus 로고
    • Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter
    • Donovan A, Brownlie A, Zhou Y, et al. Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature. 2000; 403:776–781.
    • (2000) Nature. , vol.403 , pp. 776-781
    • Donovan, A.1    Brownlie, A.2    Zhou, Y.3
  • 18
    • 0034733635 scopus 로고    scopus 로고
    • A novel mammalian iron-regulated protein involved in intracellular iron metabolism
    • Abboud S, Haile DJ. A novel mammalian iron-regulated protein involved in intracellular iron metabolism. J Biol Chem. 2000; 275:19906–19912.
    • (2000) J Biol Chem. , vol.275 , pp. 19906-19912
    • Abboud, S.1    Haile, D.J.2
  • 19
    • 0033861745 scopus 로고    scopus 로고
    • A novel duodenal ironregulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation
    • McKie AT, Marciani P, Rolfs A, et al. A novel duodenal ironregulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol Cell. 2000; 5:299–309.
    • (2000) Mol Cell. , vol.5 , pp. 299-309
    • McKie, A.T.1    Marciani, P.2    Rolfs, A.3
  • 21
    • 0032909207 scopus 로고    scopus 로고
    • Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse
    • Vulpe CD, Kuo YM, Murphy TL, et al. Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse. Nat Genet. 1999; 21:195–199.
    • (1999) Nat Genet. , vol.21 , pp. 195-199
    • Vulpe, C.D.1    Kuo, Y.M.2    Murphy, T.L.3
  • 22
    • 0032875387 scopus 로고    scopus 로고
    • Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux
    • Harris ZL, Durley AP, Man TK, Gitlin JD. Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux. Proc Natl Acad Sci USA. 1999; 96:10812–10817.
    • (1999) Proc Natl Acad Sci USA. , vol.96 , pp. 10812-10817
    • Harris, Z.L.1    Durley, A.P.2    Man, T.K.3    Gitlin, J.D.4
  • 24
    • 84923293373 scopus 로고    scopus 로고
    • The second transferrin receptor regulates red blood cell production in mice
    • Nai A, Lidonnici MR, Rausa M, et al. The second transferrin receptor regulates red blood cell production in mice. Blood. 2015; 125:1170–1179.
    • (2015) Blood. , vol.125 , pp. 1170-1179
    • Nai, A.1    Lidonnici, M.R.2    Rausa, M.3
  • 25
  • 26
    • 84937525787 scopus 로고    scopus 로고
    • SLC39A14 Is Required for the development of hepatocellular iron overload in murine models of hereditary hemochromatosis
    • Jenkitkasemwong S, Wang CY, Coffey R, et al. SLC39A14 Is Required for the development of hepatocellular iron overload in murine models of hereditary hemochromatosis. Cell Metab. 2015; 22:138–150.
    • (2015) Cell Metab. , vol.22 , pp. 138-150
    • Jenkitkasemwong, S.1    Wang, C.Y.2    Coffey, R.3
  • 27
    • 77956605615 scopus 로고    scopus 로고
    • Serum ferritin is derived primarily from macrophages through a nonclassical secretory pathway
    • Cohen LA, Gutierrez L, Weiss A, et al. Serum ferritin is derived primarily from macrophages through a nonclassical secretory pathway. Blood. 2010; 116:1574–1584.
    • (2010) Blood. , vol.116 , pp. 1574-1584
    • Cohen, L.A.1    Gutierrez, L.2    Weiss, A.3
  • 29
    • 77955886660 scopus 로고    scopus 로고
    • Iron traffics in circulation bound to a siderocalin (Ngal)-catechol complex
    • Bao G, Clifton M, Hoette TM, et al. Iron traffics in circulation bound to a siderocalin (Ngal)-catechol complex. Nat Chem Biol. 2010; 6:602–609.
    • (2010) Nat Chem Biol. , vol.6 , pp. 602-609
    • Bao, G.1    Clifton, M.2    Hoette, T.M.3
  • 30
    • 45849123222 scopus 로고    scopus 로고
    • A cytosolic iron chaperone that delivers iron to ferritin
    • Shi H, Bencze KZ, Stemmler TL, Philpott CC. A cytosolic iron chaperone that delivers iron to ferritin. Science. 2008; 320:1207–1210.
    • (2008) Science. , vol.320 , pp. 1207-1210
    • Shi, H.1    Bencze, K.Z.2    Stemmler, T.L.3    Philpott, C.C.4
  • 31
    • 0030846021 scopus 로고    scopus 로고
    • Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin
    • Babcock M, de Silva D, Oaks R, et al. Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin. Science. 1997; 276:1709–1712.
    • (1997) Science. , vol.276 , pp. 1709-1712
    • Babcock, M.1    de Silva, D.2    Oaks, R.3
  • 32
    • 33644748145 scopus 로고    scopus 로고
    • Mitoferrin is essential for erythroid iron assimilation
    • Shaw GC, Cope JJ, Li L, et al. Mitoferrin is essential for erythroid iron assimilation. Nature. 2006; 440:96–100.
    • (2006) Nature. , vol.440 , pp. 96-100
    • Shaw, G.C.1    Cope, J.J.2    Li, L.3
  • 33
    • 84870514416 scopus 로고    scopus 로고
    • The mitochondrial heme exporter FLVCR1b mediates erythroid differentiation
    • Chiabrando D, Marro S, Mercurio S, et al. The mitochondrial heme exporter FLVCR1b mediates erythroid differentiation. J Clin Invest. 2012; 122:4569–4579.
    • (2012) J Clin Invest. , vol.122 , pp. 4569-4579
    • Chiabrando, D.1    Marro, S.2    Mercurio, S.3
  • 34
    • 84899746695 scopus 로고    scopus 로고
    • Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy
    • Mancias JD, Wang X, Gygi SP, Harper JW, Kimmelman AC. Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy. Nature. 2014; 509:105–109.
    • (2014) Nature. , vol.509 , pp. 105-109
    • Mancias, J.D.1    Wang, X.2    Gygi, S.P.3    Harper, J.W.4    Kimmelman, A.C.5
  • 35
    • 84946615455 scopus 로고    scopus 로고
    • Ferritinophagy via NCOA4 is required for erythropoiesis and is regulated by iron dependent HERC2-mediated proteolysis
    • Mancias JD, Pontano Vaites L, Nissim S, et al. Ferritinophagy via NCOA4 is required for erythropoiesis and is regulated by iron dependent HERC2-mediated proteolysis. Elife. 2015; 4:e10308.
    • (2015) Elife. , vol.4
    • Mancias, J.D.1    Pontano Vaites, L.2    Nissim, S.3
  • 36
    • 38949097546 scopus 로고    scopus 로고
    • A heme export protein is required for red blood cell differentiation and iron homeostasis
    • Keel SB, Doty RT, Yang Z, et al. A heme export protein is required for red blood cell differentiation and iron homeostasis. Science. 2008; 319:825–828.
    • (2008) Science. , vol.319 , pp. 825-828
    • Keel, S.B.1    Doty, R.T.2    Yang, Z.3
  • 37
    • 50949102412 scopus 로고    scopus 로고
    • Systemic iron homeostasis and the iron-responsive element/ironregulatory protein (IRE/IRP) regulatory network
    • Muckenthaler MU, Galy B, Hentze MW. Systemic iron homeostasis and the iron-responsive element/ironregulatory protein (IRE/IRP) regulatory network. Annu Rev Nutr. 2008; 28:197–213.
    • (2008) Annu Rev Nutr. , vol.28 , pp. 197-213
    • Muckenthaler, M.U.1    Galy, B.2    Hentze, M.W.3
  • 38
    • 70350613915 scopus 로고    scopus 로고
    • Control of iron homeostasis by an iron-regulated ubiquitin ligase
    • Vashisht AA, Zumbrennen KB, Huang X, et al. Control of iron homeostasis by an iron-regulated ubiquitin ligase. Science. 2009; 326:718–721.
    • (2009) Science. , vol.326 , pp. 718-721
    • Vashisht, A.A.1    Zumbrennen, K.B.2    Huang, X.3
  • 39
    • 70350576223 scopus 로고    scopus 로고
    • An E3 ligase possessing an iron-responsive hemerythrin domain is a regulator of iron homeostasis
    • Salahudeen AA, Thompson JW, Ruiz JC, et al. An E3 ligase possessing an iron-responsive hemerythrin domain is a regulator of iron homeostasis. Science. 2009; 326:722–726.
    • (2009) Science. , vol.326 , pp. 722-726
    • Salahudeen, A.A.1    Thompson, J.W.2    Ruiz, J.C.3
  • 40
    • 38349111676 scopus 로고    scopus 로고
    • Role of the hypoxia inducible factors HIF in iron metabolism
    • Peyssonnaux C, Nizet V, Johnson RS. Role of the hypoxia inducible factors HIF in iron metabolism. Cell Cycle. 2008; 7:28–32.
    • (2008) Cell Cycle. , vol.7 , pp. 28-32
    • Peyssonnaux, C.1    Nizet, V.2    Johnson, R.S.3
  • 42
    • 58749094789 scopus 로고    scopus 로고
    • Intestinal hypoxia-inducible transcription factors are essential for iron absorption following iron deficiency
    • Shah YM, Matsubara T, Ito S, Yim SH, Gonzalez FJ. Intestinal hypoxia-inducible transcription factors are essential for iron absorption following iron deficiency. Cell Metab. 2009; 9:152–164.
    • (2009) Cell Metab. , vol.9 , pp. 152-164
    • Shah, Y.M.1    Matsubara, T.2    Ito, S.3    Yim, S.H.4    Gonzalez, F.J.5
  • 43
    • 79958146087 scopus 로고    scopus 로고
    • Hypoxia-inducible factor-2α mediates the adaptive increase of intestinal ferroportin during iron deficiency in mice
    • Taylor M, Qu A, Anderson ER, et al. Hypoxia-inducible factor-2α mediates the adaptive increase of intestinal ferroportin during iron deficiency in mice. Gastroenterology. 2011; 140:2044–2055.
    • (2011) Gastroenterology. , vol.140 , pp. 2044-2055
    • Taylor, M.1    Qu, A.2    Anderson, E.R.3
  • 44
    • 84873361483 scopus 로고    scopus 로고
    • The IRP1-HIF-2α axis coordinates iron and oxygen sensing with erythropoiesis and iron absorption
    • Anderson SA, Nizzi CP, Chang YI, et al. The IRP1-HIF-2α axis coordinates iron and oxygen sensing with erythropoiesis and iron absorption. Cell Metab. 2013; 17:282–290.
    • (2013) Cell Metab. , vol.17 , pp. 282-290
    • Anderson, S.A.1    Nizzi, C.P.2    Chang, Y.I.3
  • 45
    • 10844258104 scopus 로고    scopus 로고
    • Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization
    • Nemeth E, Tuttle MS, Powelson J, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004; 306:2090–2093.
    • (2004) Science. , vol.306 , pp. 2090-2093
    • Nemeth, E.1    Tuttle, M.S.2    Powelson, J.3
  • 46
    • 84902194073 scopus 로고    scopus 로고
    • Targeted disruption of hepcidin in the liver recapitulates the hemochromatotic phenotype
    • Zumerle S, Mathieu JR, Delga S, et al. Targeted disruption of hepcidin in the liver recapitulates the hemochromatotic phenotype. Blood. 2014; 123:3646–3650.
    • (2014) Blood. , vol.123 , pp. 3646-3650
    • Zumerle, S.1    Mathieu, J.R.2    Delga, S.3
  • 47
    • 84958780878 scopus 로고    scopus 로고
    • Hepcidin regulation in the anemia of inflammation
    • Wang CY, Babitt JL. Hepcidin regulation in the anemia of inflammation. Curr Opin Hematol. 2016; 23:189–197.
    • (2016) Curr Opin Hematol. , vol.23 , pp. 189-197
    • Wang, C.Y.1    Babitt, J.L.2
  • 48
    • 85018018795 scopus 로고    scopus 로고
    • de Benoist B, McLean E, Egli I, Cogswell M. eds., World prevalence of anaemia 1993-2005, Geneva, World Health Organization
    • de Benoist B, McLean E, Egli I, Cogswell M. eds. World prevalence of anaemia 1993-2005. WHO Global Database on Anaemia. Geneva, World Health Organization, 2008. http://www.who.int/nutrition/publications/micronutrients/anaemia_iron_deficiency/9789241596657/en/
    • (2008)
  • 50
    • 33646345152 scopus 로고    scopus 로고
    • KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease
    • National Kidney Foundation. KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. Am J Kidney Dis. 2006; 47:S1–145.
    • (2006) Am J Kidney Dis. , vol.47 , pp. S1-145
  • 51
    • 84896733066 scopus 로고    scopus 로고
    • The iron cycle in chronic kidney disease (CKD): From genetics and experimental models to CKD patients
    • Zumbrennen-Bullough K, Babitt JL. The iron cycle in chronic kidney disease (CKD): From genetics and experimental models to CKD patients. Nephrol Dial Transplant. 2014; 29:263–273.
    • (2014) Nephrol Dial Transplant. , vol.29 , pp. 263-273
    • Zumbrennen-Bullough, K.1    Babitt, J.L.2
  • 52
    • 12844260664 scopus 로고    scopus 로고
    • Identification of a human mutation of DMT1 in a patient with microcytic anemia and iron overload
    • Mims MP, Guan Y, Pospisilova D, et al. Identification of a human mutation of DMT1 in a patient with microcytic anemia and iron overload. Blood. 2005; 105:1337–1342.
    • (2005) Blood. , vol.105 , pp. 1337-1342
    • Mims, M.P.1    Guan, Y.2    Pospisilova, D.3
  • 55
    • 42649118442 scopus 로고    scopus 로고
    • Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA)
    • Finberg KE, Heeney MM, Campagna DR, et al. Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA). Nat Genet. 2008; 40:569–571.
    • (2008) Nat Genet. , vol.40 , pp. 569-571
    • Finberg, K.E.1    Heeney, M.M.2    Campagna, D.R.3
  • 56
    • 44449177930 scopus 로고    scopus 로고
    • The serine protease TMPRSS6 is required to sense iron deficiency
    • Du X, She E, Gelbart T, et al. The serine protease TMPRSS6 is required to sense iron deficiency. Science. 2008; 320:1088–1092.
    • (2008) Science. , vol.320 , pp. 1088-1092
    • Du, X.1    She, E.2    Gelbart, T.3
  • 57
    • 84952802841 scopus 로고    scopus 로고
    • Iron and the liver
    • Pietrangelo A. Iron and the liver. Liver Int. 2016; 36:116–123.
    • (2016) Liver Int. , vol.36 , pp. 116-123
    • Pietrangelo, A.1
  • 58
    • 84956923279 scopus 로고    scopus 로고
    • Ineffective erythropoiesis and regulation of iron status in iron loading anaemias
    • Camaschella C, Nai A. Ineffective erythropoiesis and regulation of iron status in iron loading anaemias. Br J Haematol. 2016; 172:512–523.
    • (2016) Br J Haematol. , vol.172 , pp. 512-523
    • Camaschella, C.1    Nai, A.2
  • 59
    • 20244388240 scopus 로고    scopus 로고
    • Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis
    • Roetto A, Papanikolaou G, Politou M, et al. Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat Genet. 2003; 33:21–22.
    • (2003) Nat Genet. , vol.33 , pp. 21-22
    • Roetto, A.1    Papanikolaou, G.2    Politou, M.3
  • 60
    • 9344224529 scopus 로고    scopus 로고
    • A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis
    • Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996; 13:399–408.
    • (1996) Nat Genet. , vol.13 , pp. 399-408
    • Feder, J.N.1    Gnirke, A.2    Thomas, W.3
  • 61
    • 0034022636 scopus 로고    scopus 로고
    • The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22
    • Camaschella C, Roetto A, Calì A, et al. The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat Genet. 2000; 25:14–15.
    • (2000) Nat Genet. , vol.25 , pp. 14-15
    • Camaschella, C.1    Roetto, A.2    Calì, A.3
  • 62
    • 9144252017 scopus 로고    scopus 로고
    • Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis
    • Papanikolaou G, Samuels ME, Ludwig EH, et al. Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat Genet. 2004; 36:77–82.
    • (2004) Nat Genet. , vol.36 , pp. 77-82
    • Papanikolaou, G.1    Samuels, M.E.2    Ludwig, E.H.3
  • 63
    • 23044508432 scopus 로고    scopus 로고
    • Resistance to hepcidin is conferred by hemochromatosis-associated mutations of ferroportin
    • Drakesmith H, Schimanski LM, Ormerod E, et al. Resistance to hepcidin is conferred by hemochromatosis-associated mutations of ferroportin. Blood. 2005; 106:1092–1097.
    • (2005) Blood. , vol.106 , pp. 1092-1097
    • Drakesmith, H.1    Schimanski, L.M.2    Ormerod, E.3
  • 64
    • 17944380796 scopus 로고    scopus 로고
    • Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene
    • Montosi G, Donovan A, Totaro A, et al. Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J Clin Invest. 2001; 108:619–623.
    • (2001) J Clin Invest. , vol.108 , pp. 619-623
    • Montosi, G.1    Donovan, A.2    Totaro, A.3
  • 65
    • 84903578007 scopus 로고    scopus 로고
    • Identification of erythroferrone as an erythroid regulator of iron metabolism
    • Kautz L, Jung G, Valore EV, Rivella S, Nemeth E, Ganz T. Identification of erythroferrone as an erythroid regulator of iron metabolism. Nat Genet. 2014; 46:678–684.
    • (2014) Nat Genet. , vol.46 , pp. 678-684
    • Kautz, L.1    Jung, G.2    Valore, E.V.3    Rivella, S.4    Nemeth, E.5    Ganz, T.6
  • 66
    • 84943786773 scopus 로고    scopus 로고
    • Understanding the recent increase in ferritin levels in United States dialysis patients: Potential impact of changes in intravenous iron and erythropoiesis-stimulating agent dosing
    • Karaboyas A, Zee J, Morgenstern H, et al. Understanding the recent increase in ferritin levels in United States dialysis patients: Potential impact of changes in intravenous iron and erythropoiesis-stimulating agent dosing. Clin J Am Soc Nephrol. 2015; 10:1814–1821.
    • (2015) Clin J Am Soc Nephrol. , vol.10 , pp. 1814-1821
    • Karaboyas, A.1    Zee, J.2    Morgenstern, H.3
  • 67
    • 33744919003 scopus 로고    scopus 로고
    • High prevalence of abnormal glucose homeostasis secondary to decreased insulin secretion in individuals with hereditary haemochromatosis
    • McClain DA, Abraham D, Rogers J, et al. High prevalence of abnormal glucose homeostasis secondary to decreased insulin secretion in individuals with hereditary haemochromatosis. Diabetologia. 2006; 49:1661–1669.
    • (2006) Diabetologia. , vol.49 , pp. 1661-1669
    • McClain, D.A.1    Abraham, D.2    Rogers, J.3
  • 68
    • 68949208818 scopus 로고    scopus 로고
    • Differences in the prevalence of growth, endocrine and vitamin D abnormalities among the various thalassaemia syndromes in North America
    • Vogiatzi MG, Macklin EA, Trachtenberg FL, et al. Differences in the prevalence of growth, endocrine and vitamin D abnormalities among the various thalassaemia syndromes in North America. Br J Haematol. 2009; 146:546–556.
    • (2009) Br J Haematol. , vol.146 , pp. 546-556
    • Vogiatzi, M.G.1    Macklin, E.A.2    Trachtenberg, F.L.3
  • 69
    • 0033364044 scopus 로고    scopus 로고
    • Diabetes and serum ferritin concentration among U.S. adults
    • Ford ES, Cogswell ME. Diabetes and serum ferritin concentration among U.S. adults. Diabetes Care. 1999; 22:1978–1983.
    • (1999) Diabetes Care. , vol.22 , pp. 1978-1983
    • Ford, E.S.1    Cogswell, M.E.2
  • 70
    • 14744290384 scopus 로고    scopus 로고
    • Dietary iron intake and blood donations in relation to risk of type 2 diabetes in men: A prospective cohort study
    • Jiang R, Ma J, Ascherio A, Stampfer MJ, Willett WC, Hu FB. Dietary iron intake and blood donations in relation to risk of type 2 diabetes in men: A prospective cohort study. Am J Clin Nutr. 2004; 79:70–75.
    • (2004) Am J Clin Nutr. , vol.79 , pp. 70-75
    • Jiang, R.1    Ma, J.2    Ascherio, A.3    Stampfer, M.J.4    Willett, W.C.5    Hu, F.B.6
  • 71
    • 4444230462 scopus 로고    scopus 로고
    • A prospective study of red meat consumption and type 2 diabetes in middle-aged and elderly women: The women's health study
    • Song Y, Manson JE, Buring JE, Liu S. A prospective study of red meat consumption and type 2 diabetes in middle-aged and elderly women: The women's health study. Diabetes Care. 2004; 27:2108–2115.
    • (2004) Diabetes Care. , vol.27 , pp. 2108-2115
    • Song, Y.1    Manson, J.E.2    Buring, J.E.3    Liu, S.4
  • 72
    • 1442314640 scopus 로고    scopus 로고
    • Body iron stores in relation to risk of type 2 diabetes in apparently healthy women
    • Jiang R, Manson JE, Meigs JB, Ma J, Rifai N, Hu FB. Body iron stores in relation to risk of type 2 diabetes in apparently healthy women. JAMA. 2004; 291:711–717.
    • (2004) JAMA. , vol.291 , pp. 711-717
    • Jiang, R.1    Manson, J.E.2    Meigs, J.B.3    Ma, J.4    Rifai, N.5    Hu, F.B.6
  • 73
    • 0015295917 scopus 로고
    • Observations on the pathogenesis, complications and treatment of diabetes in 115 cases of haemochromatosis
    • Dymock IW, Cassar J, Pyke DA, Oakley WG, Williams R. Observations on the pathogenesis, complications and treatment of diabetes in 115 cases of haemochromatosis. Am J Med. 1972; 52:203–210.
    • (1972) Am J Med. , vol.52 , pp. 203-210
    • Dymock, I.W.1    Cassar, J.2    Pyke, D.A.3    Oakley, W.G.4    Williams, R.5
  • 74
    • 12544253460 scopus 로고    scopus 로고
    • Glucose metabolism disorders improvement in patients with thalassaemia major after 24-36 months of intensive chelation therapy
    • Platis O, Anagnostopoulos G, Farmaki K, Posantzis M, Gotsis E, Tolis G. Glucose metabolism disorders improvement in patients with thalassaemia major after 24-36 months of intensive chelation therapy. Pediatr Endocrinol Rev. 2004; 2:279–281.
    • (2004) Pediatr Endocrinol Rev. , vol.2 , pp. 279-281
    • Platis, O.1    Anagnostopoulos, G.2    Farmaki, K.3    Posantzis, M.4    Gotsis, E.5    Tolis, G.6
  • 76
  • 77
    • 9244230038 scopus 로고    scopus 로고
    • Oxidative stress, beta-cell apoptosis, and decreased insulin secretory capacity in mouse models of hemochromatosis
    • Cooksey RC, Jouihan HA, Ajioka RS, et al. Oxidative stress, beta-cell apoptosis, and decreased insulin secretory capacity in mouse models of hemochromatosis. Endocrinology. 2004; 145:5305–5312.
    • (2004) Endocrinology. , vol.145 , pp. 5305-5312
    • Cooksey, R.C.1    Jouihan, H.A.2    Ajioka, R.S.3
  • 78
    • 84867167258 scopus 로고    scopus 로고
    • Adipocyte iron regulates adiponectin and insulin sensitivity
    • Gabrielsen JS, Gao Y, Simcox JA, et al. Adipocyte iron regulates adiponectin and insulin sensitivity. J Clin Invest. 2012; 122:3529–3540.
    • (2012) J Clin Invest. , vol.122 , pp. 3529-3540
    • Gabrielsen, J.S.1    Gao, Y.2    Simcox, J.A.3
  • 79
    • 84880327550 scopus 로고    scopus 로고
    • American heart association committee on heart failure and transplantation of the council on clinical cardiology and council on cardiovascular radiology and imaging. Cardiovascular function and treatment in β-thalassemia major: A consensus statement from the American Heart Association
    • Pennell DJ, Udelson JE, Arai AE, et al. American heart association committee on heart failure and transplantation of the council on clinical cardiology and council on cardiovascular radiology and imaging. Cardiovascular function and treatment in β-thalassemia major: A consensus statement from the American Heart Association. Circulation. 2013; 128:281–308.
    • (2013) Circulation. , vol.128 , pp. 281-308
    • Pennell, D.J.1    Udelson, J.E.2    Arai, A.E.3
  • 80
    • 78149284772 scopus 로고    scopus 로고
    • Iron-overload cardiomyopathy: Pathophysiology, diagnosis, and treatment
    • Murphy CJ, Oudit GY. Iron-overload cardiomyopathy: Pathophysiology, diagnosis, and treatment. J Card Fail. 2010; 16:888–900.
    • (2010) J Card Fail. , vol.16 , pp. 888-900
    • Murphy, C.J.1    Oudit, G.Y.2
  • 81
    • 84875474830 scopus 로고    scopus 로고
    • Iron deficiency in chronic heart failure: An international pooled analysis
    • Klip IT, Comin-Colet J, Voors AA, et al. Iron deficiency in chronic heart failure: An international pooled analysis. Am Heart J. 2013; 165:575–582. e573.
    • (2013) Am Heart J. , vol.165 , pp. 575-582
    • Klip, I.T.1    Comin-Colet, J.2    Voors, A.A.3
  • 82
    • 84884553015 scopus 로고    scopus 로고
    • Iron deficiency is a key determinant of health-related quality of life in patients with chronic heart failure regardless of anaemia status
    • Comin-Colet J, Enjuanes C, Gonzalez G, et al. Iron deficiency is a key determinant of health-related quality of life in patients with chronic heart failure regardless of anaemia status. Eur J Heart Fail. 2013; 15:1164–1172.
    • (2013) Eur J Heart Fail. , vol.15 , pp. 1164-1172
    • Comin-Colet, J.1    Enjuanes, C.2    Gonzalez, G.3
  • 83
    • 72449156527 scopus 로고    scopus 로고
    • Ferric carboxymaltose in patients with heart failure and iron deficiency
    • Anker SD, Comin Colet J, Filippatos G, et al. Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med. 2009; 361:2436–2448.
    • (2009) N Engl J Med. , vol.361 , pp. 2436-2448
    • Anker, S.D.1    Comin Colet, J.2    Filippatos, G.3
  • 84
    • 84925275800 scopus 로고    scopus 로고
    • Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency
    • Ponikowski P, van Veldhuisen DJ, Comin-Colet J, et al. Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency. Eur Heart J. 2015; 36:657–668.
    • (2015) Eur Heart J. , vol.36 , pp. 657-668
    • Ponikowski, P.1    van Veldhuisen, D.J.2    Comin-Colet, J.3
  • 85
    • 0019434645 scopus 로고
    • Iron and the sex difference in heart disease risk
    • Sullivan JL. Iron and the sex difference in heart disease risk. Lancet. 1981; 1:1293–1294.
    • (1981) Lancet. , vol.1 , pp. 1293-1294
    • Sullivan, J.L.1
  • 88
    • 0030778795 scopus 로고    scopus 로고
    • Body iron stores and the risk of carotid atherosclerosis: Prospective results from the Bruneck study
    • Kiechl S, Willeit J, Egger G, Poewe W, Oberhollenzer F. Body iron stores and the risk of carotid atherosclerosis: Prospective results from the Bruneck study. Circulation. 1997; 96:3300–3307.
    • (1997) Circulation. , vol.96 , pp. 3300-3307
    • Kiechl, S.1    Willeit, J.2    Egger, G.3    Poewe, W.4    Oberhollenzer, F.5
  • 89
    • 0033596677 scopus 로고    scopus 로고
    • Coronary heart disease and iron status: Meta-analyses of prospective studies
    • Danesh J, Appleby P. Coronary heart disease and iron status: Meta-analyses of prospective studies. Circulation. 1999; 99:852–854.
    • (1999) Circulation. , vol.99 , pp. 852-854
    • Danesh, J.1    Appleby, P.2
  • 90
    • 84923950749 scopus 로고    scopus 로고
    • Iron sucrose accelerates early atherogenesis by increasing superoxide production and upregulating adhesion molecules in CKD
    • Kuo KL, Hung SC, Lee TS, Tarng DC. Iron sucrose accelerates early atherogenesis by increasing superoxide production and upregulating adhesion molecules in CKD. J Am Soc Nephrol. 2014; 25:2596–2606.
    • (2014) J Am Soc Nephrol. , vol.25 , pp. 2596-2606
    • Kuo, K.L.1    Hung, S.C.2    Lee, T.S.3    Tarng, D.C.4
  • 91
    • 67349180293 scopus 로고    scopus 로고
    • Iron in arterial plaque: Modifiable risk factor for atherosclerosis
    • Sullivan JL. Iron in arterial plaque: Modifiable risk factor for atherosclerosis. Biochim Biophys Acta. 2009; 1790:718–723.
    • (2009) Biochim Biophys Acta. , vol.1790 , pp. 718-723
    • Sullivan, J.L.1
  • 92
    • 84890237720 scopus 로고    scopus 로고
    • Testing the iron hypothesis in a mouse model of atherosclerosis
    • Kautz L, Gabayan V, Wang X, et al. Testing the iron hypothesis in a mouse model of atherosclerosis. Cell Rep. 2013; 5:1436–1442.
    • (2013) Cell Rep. , vol.5 , pp. 1436-1442
    • Kautz, L.1    Gabayan, V.2    Wang, X.3
  • 93
    • 84920107364 scopus 로고    scopus 로고
    • Data from the Dialysis Outcomes and Practice Patterns Study validate an association between high intravenous iron doses and mortality
    • Bailie GR, Larkina M, Goodkin DA, et al. Data from the Dialysis Outcomes and Practice Patterns Study validate an association between high intravenous iron doses and mortality. Kidney Int. 2015; 87:162–168.
    • (2015) Kidney Int. , vol.87 , pp. 162-168
    • Bailie, G.R.1    Larkina, M.2    Goodkin, D.A.3
  • 94
  • 95
    • 84926442768 scopus 로고    scopus 로고
    • Developing evidence to inform decisions about effectiveness (DEcIDE) network patient outcomes in end stage renal disease study investigators. Intravenous iron exposure and mortality in patients on hemodialysis
    • Miskulin DC, Tangri N, Bandeen-Roche K, et al. Developing evidence to inform decisions about effectiveness (DEcIDE) network patient outcomes in end stage renal disease study investigators. Intravenous iron exposure and mortality in patients on hemodialysis. Clin J Am Soc Nephrol. 2014; 9:1930–1939.
    • (2014) Clin J Am Soc Nephrol. , vol.9 , pp. 1930-1939
    • Miskulin, D.C.1    Tangri, N.2    Bandeen-Roche, K.3
  • 97
    • 0038670759 scopus 로고    scopus 로고
    • Iron deficiency alters brain development and functioning
    • Beard J. Iron deficiency alters brain development and functioning. J Nutr. 2003; 133:1468S–1472S.
    • (2003) J Nutr. , vol.133 , pp. 1468S-1472S
    • Beard, J.1
  • 98
    • 58149396754 scopus 로고    scopus 로고
    • Brain iron deficiency and excess; cognitive impairment and neurodegeneration with involvement of striatum and hippocampus
    • Youdim MB. Brain iron deficiency and excess; cognitive impairment and neurodegeneration with involvement of striatum and hippocampus. Neurotox Res. 2008; 14:45–56.
    • (2008) Neurotox Res. , vol.14 , pp. 45-56
    • Youdim, M.B.1
  • 99
    • 84894475785 scopus 로고    scopus 로고
    • Brain iron homeostasis: From molecular mechanisms to clinical significance and therapeutic opportunities
    • Singh N, Haldar S, Tripathi AK, et al. Brain iron homeostasis: From molecular mechanisms to clinical significance and therapeutic opportunities. Antioxid Redox Signal. 2014; 20:1324–1363.
    • (2014) Antioxid Redox Signal. , vol.20 , pp. 1324-1363
    • Singh, N.1    Haldar, S.2    Tripathi, A.K.3
  • 101
    • 84880805523 scopus 로고    scopus 로고
    • Iron metabolism in the CNS: Implications for neurodegenerative diseases
    • Rouault TA. Iron metabolism in the CNS: Implications for neurodegenerative diseases. Nat Rev Neurosci. 2013; 14:551–564.
    • (2013) Nat Rev Neurosci. , vol.14 , pp. 551-564
    • Rouault, T.A.1
  • 102
    • 84979698328 scopus 로고    scopus 로고
    • Loss of Frataxin induces iron toxicity, sphingolipid synthesis, and Pdk1/Mef2 activation, leading to neurodegeneration
    • Chen K, Lin G, Haelterman NA, et al. Loss of Frataxin induces iron toxicity, sphingolipid synthesis, and Pdk1/Mef2 activation, leading to neurodegeneration. Elife. 2016; 5:e20732.
    • (2016) Elife. , vol.5
    • Chen, K.1    Lin, G.2    Haelterman, N.A.3
  • 103
    • 0347928847 scopus 로고    scopus 로고
    • An iron-responsive element type II in the 5'-untranslated region of the Alzheimer's amyloid precursor protein transcript
    • Rogers JT, Randall JD, Cahill CM, et al. An iron-responsive element type II in the 5'-untranslated region of the Alzheimer's amyloid precursor protein transcript. J Biol Chem. 2002; 277:45518–45528.
    • (2002) J Biol Chem. , vol.277 , pp. 45518-45528
    • Rogers, J.T.1    Randall, J.D.2    Cahill, C.M.3
  • 104
    • 33847320669 scopus 로고    scopus 로고
    • The 5'-untranslated region of Parkinson's disease alpha-synuclein messengerRNA contains a predicted iron responsive element
    • Friedlich AL, Tanzi RE, Rogers JT. The 5'-untranslated region of Parkinson's disease alpha-synuclein messengerRNA contains a predicted iron responsive element. Mol Psychiatry. 2007; 12:222–223.
    • (2007) Mol Psychiatry. , vol.12 , pp. 222-223
    • Friedlich, A.L.1    Tanzi, R.E.2    Rogers, J.T.3
  • 105
    • 77956647381 scopus 로고    scopus 로고
    • Iron-export ferroxidase activity of β-amyloid precursor protein is inhibited by zinc in Alzheimer's disease
    • Duce JA, Tsatsanis A, Cater MA, et al. Iron-export ferroxidase activity of β-amyloid precursor protein is inhibited by zinc in Alzheimer's disease. Cell. 2010; 142:857–867.
    • (2010) Cell. , vol.142 , pp. 857-867
    • Duce, J.A.1    Tsatsanis, A.2    Cater, M.A.3
  • 106
    • 84914693430 scopus 로고    scopus 로고
    • β-Amyloid precursor protein does not possess ferroxidase activity but does stabilize the cell surface ferrous iron exporter ferroportin
    • Wong BX, Tsatsanis A, Lim LQ, Adlard PA, Bush AI, Duce JA. β-Amyloid precursor protein does not possess ferroxidase activity but does stabilize the cell surface ferrous iron exporter ferroportin. PLoS One. 2014; 9:e114174
    • (2014) PLoS One. , vol.9
    • Wong, B.X.1    Tsatsanis, A.2    Lim, L.Q.3    Adlard, P.A.4    Bush, A.I.5    Duce, J.A.6
  • 107
    • 57449092273 scopus 로고    scopus 로고
    • Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease
    • Salazar J, Mena N, Hunot S, et al. Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease. Proc Natl Acad Sci USA. 2008; 105:18578–18583.
    • (2008) Proc Natl Acad Sci USA. , vol.105 , pp. 18578-18583
    • Salazar, J.1    Mena, N.2    Hunot, S.3
  • 108
    • 78650695967 scopus 로고    scopus 로고
    • Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson's disease
    • Jin L, Wang J, Zhao L, et al. Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson's disease. Brain. 2011; 134:50–58.
    • (2011) Brain. , vol.134 , pp. 50-58
    • Jin, L.1    Wang, J.2    Zhao, L.3
  • 109
    • 0035127525 scopus 로고    scopus 로고
    • Increased cancer risk in a cohort of 230 patients with hereditary hemochromatosis in comparison to matched control patients with non-iron-related chronic liver disease
    • Fracanzani AL, Conte D, Fraquelli M, et al. Increased cancer risk in a cohort of 230 patients with hereditary hemochromatosis in comparison to matched control patients with non-iron-related chronic liver disease. Hepatology. 2001; 33:647–651.
    • (2001) Hepatology. , vol.33 , pp. 647-651
    • Fracanzani, A.L.1    Conte, D.2    Fraquelli, M.3
  • 110
    • 77950620367 scopus 로고    scopus 로고
    • HFE C282Y homozygotes are at increased risk of breast and colorectal cancer
    • Osborne NJ, Gurrin LC, Allen KJ, et al. HFE C282Y homozygotes are at increased risk of breast and colorectal cancer. Hepatology. 2010; 51:1311–1318.
    • (2010) Hepatology. , vol.51 , pp. 1311-1318
    • Osborne, N.J.1    Gurrin, L.C.2    Allen, K.J.3
  • 111
    • 9144224804 scopus 로고    scopus 로고
    • Hepatocellular carcinoma in the thalassaemia syndromes
    • Borgna-Pignatti C, Vergine G, Lombardo T, et al. Hepatocellular carcinoma in the thalassaemia syndromes. Br J Haematol. 2004; 124:114–117.
    • (2004) Br J Haematol. , vol.124 , pp. 114-117
    • Borgna-Pignatti, C.1    Vergine, G.2    Lombardo, T.3
  • 113
    • 84923217504 scopus 로고    scopus 로고
    • Cancer cells with irons in the fire
    • Bystrom LM, Rivella S. Cancer cells with irons in the fire. Free Radic Biol Med. 2015; 79:337–342.
    • (2015) Free Radic Biol Med. , vol.79 , pp. 337-342
    • Bystrom, L.M.1    Rivella, S.2
  • 114
    • 77955607931 scopus 로고    scopus 로고
    • Ferroportin and iron regulation in breast cancer progression and prognosis
    • Pinnix ZK, Miller LD, Wang W, et al. Ferroportin and iron regulation in breast cancer progression and prognosis. Sci Transl Med. 2010; 2:43ra56.
    • (2010) Sci Transl Med. , vol.2 , pp. 43ra56
    • Pinnix, Z.K.1    Miller, L.D.2    Wang, W.3
  • 115
    • 65449117261 scopus 로고    scopus 로고
    • Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: A meta-analysis of randomised trials
    • Bohlius J, Schmidlin K, Brillant C, et al. Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: A meta-analysis of randomised trials. Lancet. 2009; 373:1532–1542.
    • (2009) Lancet. , vol.373 , pp. 1532-1542
    • Bohlius, J.1    Schmidlin, K.2    Brillant, C.3
  • 116
    • 70949108082 scopus 로고    scopus 로고
    • A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease
    • Pfeffer MA, Burdmann EA, Chen CY, et al. A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med. 2009; 361:2019–2032.
    • (2009) N Engl J Med. , vol.361 , pp. 2019-2032
    • Pfeffer, M.A.1    Burdmann, E.A.2    Chen, C.Y.3
  • 117
    • 0027324385 scopus 로고
    • Increase in bleomycin-detectable iron in ischaemia/reperfusion injury to rat kidneys
    • Baliga R, Ueda N, Shah SV. Increase in bleomycin-detectable iron in ischaemia/reperfusion injury to rat kidneys. Biochem J. 1993; 291:901–905.
    • (1993) Biochem J. , vol.291 , pp. 901-905
    • Baliga, R.1    Ueda, N.2    Shah, S.V.3
  • 118
    • 0031933285 scopus 로고    scopus 로고
    • In vitro and in vivo evidence suggesting a role for iron in cisplatin-induced nephrotoxicity
    • Baliga R, Zhang Z, Baliga M, Ueda N, Shah SV. In vitro and in vivo evidence suggesting a role for iron in cisplatin-induced nephrotoxicity. Kidney Int. 1998; 53:394–401.
    • (1998) Kidney Int. , vol.53 , pp. 394-401
    • Baliga, R.1    Zhang, Z.2    Baliga, M.3    Ueda, N.4    Shah, S.V.5
  • 121
    • 84885094738 scopus 로고    scopus 로고
    • Increased renal iron accumulation in hypertensive nephropathy of salt-loaded hypertensive rats
    • Naito Y, Sawada H, Oboshi M, et al. Increased renal iron accumulation in hypertensive nephropathy of salt-loaded hypertensive rats. PLoS One. 2013; 8:e75906.
    • (2013) PLoS One. , vol.8
    • Naito, Y.1    Sawada, H.2    Oboshi, M.3
  • 122
    • 84913582286 scopus 로고    scopus 로고
    • Synchronized renal tubular cell death involves ferroptosis
    • Linkermann A, Skouta R, Himmerkus N, et al. Synchronized renal tubular cell death involves ferroptosis. Proc Natl Acad Sci USA. 2014; 111:16836–16841.
    • (2014) Proc Natl Acad Sci USA. , vol.111 , pp. 16836-16841
    • Linkermann, A.1    Skouta, R.2    Himmerkus, N.3
  • 123
    • 84937979950 scopus 로고    scopus 로고
    • Hepcidin mitigates renal ischemia-reperfusion injury by modulating systemic iron homeostasis
    • Scindia Y, Dey P, Thirunagari A, et al. Hepcidin mitigates renal ischemia-reperfusion injury by modulating systemic iron homeostasis. J Am Soc Nephrol. 2015; 26:2800–2814.
    • (2015) J Am Soc Nephrol. , vol.26 , pp. 2800-2814
    • Scindia, Y.1    Dey, P.2    Thirunagari, A.3
  • 124
    • 0023774805 scopus 로고
    • Role of iron in postischemic renal injury in the rat
    • Paller MS, Hedlund BE. Role of iron in postischemic renal injury in the rat. Kidney Int. 1988; 34:474–480.
    • (1988) Kidney Int. , vol.34 , pp. 474-480
    • Paller, M.S.1    Hedlund, B.E.2
  • 125
    • 84885045002 scopus 로고    scopus 로고
    • Proximal tubule H-ferritin mediates iron trafficking in acute kidney injury
    • Zarjou A, Bolisetty S, Joseph R, et al. Proximal tubule H-ferritin mediates iron trafficking in acute kidney injury. J Clin Invest. 2013; 123:4423–4434.
    • (2013) J Clin Invest. , vol.123 , pp. 4423-4434
    • Zarjou, A.1    Bolisetty, S.2    Joseph, R.3
  • 126
    • 33746552172 scopus 로고    scopus 로고
    • Heme oxygenase-1: A provenance for cytoprotective pathways in the kidney and other tissues
    • Nath KA. Heme oxygenase-1: A provenance for cytoprotective pathways in the kidney and other tissues. Kidney Int. 2006; 70:432–443.
    • (2006) Kidney Int. , vol.70 , pp. 432-443
    • Nath, K.A.1
  • 127
    • 84988354702 scopus 로고    scopus 로고
    • Combined iron sucrose and protoporphyrin treatment protects against ischemic and toxin-mediated acute renal failure
    • Zager RA, Johnson AC, Frostad KB. Combined iron sucrose and protoporphyrin treatment protects against ischemic and toxin-mediated acute renal failure. Kidney Int. 2016; 90:67–76.
    • (2016) Kidney Int. , vol.90 , pp. 67-76
    • Zager, R.A.1    Johnson, A.C.2    Frostad, K.B.3
  • 128
    • 29044450387 scopus 로고    scopus 로고
    • Bone mineral density in men with genetic hemochromatosis and HFE gene mutation
    • Guggenbuhl P, Deugnier Y, Boisdet JF, et al. Bone mineral density in men with genetic hemochromatosis and HFE gene mutation. Osteoporos Int. 2005; 16:1809–1814.
    • (2005) Osteoporos Int. , vol.16 , pp. 1809-1814
    • Guggenbuhl, P.1    Deugnier, Y.2    Boisdet, J.F.3
  • 129
    • 61849146917 scopus 로고    scopus 로고
    • Bone disease in thalassemia: A frequent and still unresolved problem
    • Vogiatzi MA, Macklin EA, Fung EB, et al. Bone disease in thalassemia: A frequent and still unresolved problem. J Bone Miner Res. 2009; 24:543–557.
    • (2009) J Bone Miner Res. , vol.24 , pp. 543-557
    • Vogiatzi, M.A.1    Macklin, E.A.2    Fung, E.B.3
  • 130
    • 0042383381 scopus 로고    scopus 로고
    • Bone histomorphometry in children and adolescents with beta-thalassemia disease: Iron-associated focal osteomalacia
    • Mahachoklertwattana P, Sirikulchayanonta V, Chuansumrit A, et al. Bone histomorphometry in children and adolescents with beta-thalassemia disease: Iron-associated focal osteomalacia. J Clin Endocrinol Metab. 2003; 88:3966–3972.
    • (2003) J Clin Endocrinol Metab. , vol.88 , pp. 3966-3972
    • Mahachoklertwattana, P.1    Sirikulchayanonta, V.2    Chuansumrit, A.3
  • 131
  • 132
    • 84946130633 scopus 로고    scopus 로고
    • Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production
    • David V, Martin A, Isakova T, et al. Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production. Kidney Int. 2016; 89:135–146.
    • (2016) Kidney Int. , vol.89 , pp. 135-146
    • David, V.1    Martin, A.2    Isakova, T.3
  • 133
    • 81755163635 scopus 로고    scopus 로고
    • Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice
    • Farrow EG, Yu X, Summers LJ, et al. Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice. Proc Natl Acad Sci USA. 2011; 108:E1146–E1155.
    • (2011) Proc Natl Acad Sci USA. , vol.108 , pp. E1146-E1155
    • Farrow, E.G.1    Yu, X.2    Summers, L.J.3
  • 134
    • 80655147297 scopus 로고    scopus 로고
    • Iron modifies plasma FGF23 differently in autosomal dominant hypophosphatemic rickets and healthy humans
    • Imel EA, Peacock M, Gray AK, et al. Iron modifies plasma FGF23 differently in autosomal dominant hypophosphatemic rickets and healthy humans. J Clin Endocrinol Metab. 2011; 96:3541–3549.
    • (2011) J Clin Endocrinol Metab. , vol.96 , pp. 3541-3549
    • Imel, E.A.1    Peacock, M.2    Gray, A.K.3
  • 135
    • 84937979159 scopus 로고    scopus 로고
    • Iron homeostasis in host defence and inflammation
    • Ganz T, Nemeth E. Iron homeostasis in host defence and inflammation. Nat Rev Immunol. 2015; 15:500–510.
    • (2015) Nat Rev Immunol. , vol.15 , pp. 500-510
    • Ganz, T.1    Nemeth, E.2
  • 136
    • 84920905125 scopus 로고    scopus 로고
    • Hepcidin-induced hypoferremia is a critical host defense mechanism against the siderophilic bacterium Vibrio vulnificus
    • Arezes J, Jung G, Gabayan V, et al. Hepcidin-induced hypoferremia is a critical host defense mechanism against the siderophilic bacterium Vibrio vulnificus. Cell Host Microbe. 2015; 17:47–57.
    • (2015) Cell Host Microbe. , vol.17 , pp. 47-57
    • Arezes, J.1    Jung, G.2    Gabayan, V.3
  • 137
    • 30444459334 scopus 로고    scopus 로고
    • Effects of routine prophylactic supplementation with iron and folic acid on admission to hospital and mortality in preschool children in a high malaria transmission setting: Community-based, randomised, placebo-controlled trial
    • Sazawal S, Black RE, Ramsan M, et al. Effects of routine prophylactic supplementation with iron and folic acid on admission to hospital and mortality in preschool children in a high malaria transmission setting: Community-based, randomised, placebo-controlled trial. Lancet. 2006; 367:133–143.
    • (2006) Lancet. , vol.367 , pp. 133-143
    • Sazawal, S.1    Black, R.E.2    Ramsan, M.3
  • 138
    • 84879888176 scopus 로고    scopus 로고
    • Effect of provision of daily zinc and iron with several micronutrients on growth and morbidity among young children in Pakistan: A cluster-randomised trial
    • Soofi S, Cousens S, Iqbal SP, et al. Effect of provision of daily zinc and iron with several micronutrients on growth and morbidity among young children in Pakistan: A cluster-randomised trial. Lancet. 2013; 382:29–40.
    • (2013) Lancet. , vol.382 , pp. 29-40
    • Soofi, S.1    Cousens, S.2    Iqbal, S.P.3
  • 139
    • 0018166595 scopus 로고
    • The adverse effect of iron repletion on the course of certain infections
    • Murray MJ, Murray AB, Murray MB, Murray CJ. The adverse effect of iron repletion on the course of certain infections. Br Med J. 1978; 2:1113–1135.
    • (1978) Br Med J. , vol.2 , pp. 1113-1135
    • Murray, M.J.1    Murray, A.B.2    Murray, M.B.3    Murray, C.J.4
  • 140
    • 84943144463 scopus 로고    scopus 로고
    • Rapidly escalating hepcidin and associated serum iron starvation are features of the acute response to typhoid infection in humans
    • Darton TC, Blohmke CJ, Giannoulatou E, et al. Rapidly escalating hepcidin and associated serum iron starvation are features of the acute response to typhoid infection in humans. PLoS Negl Trop Dis. 2015; 9:e0004029.
    • (2015) PLoS Negl Trop Dis. , vol.9
    • Darton, T.C.1    Blohmke, C.J.2    Giannoulatou, E.3
  • 141
    • 84898042156 scopus 로고    scopus 로고
    • Inverse agonist of estrogen-related receptor γ controls Salmonella typhimurium infection by modulating host iron homeostasis
    • Kim DK, Jeong JH, Lee JM, et al. Inverse agonist of estrogen-related receptor γ controls Salmonella typhimurium infection by modulating host iron homeostasis. Nat Med. 2014; 20:419–424.
    • (2014) Nat Med. , vol.20 , pp. 419-424
    • Kim, D.K.1    Jeong, J.H.2    Lee, J.M.3
  • 142
    • 70449394604 scopus 로고    scopus 로고
    • Selective modulation of TLR4-activated inflammatory responses by altered iron homeostasis in mice
    • Wang L, Harrington L, Trebicka E, et al. Selective modulation of TLR4-activated inflammatory responses by altered iron homeostasis in mice. J Clin Invest. 2009; 119:3322–3328.
    • (2009) J Clin Invest. , vol.119 , pp. 3322-3328
    • Wang, L.1    Harrington, L.2    Trebicka, E.3
  • 143
    • 79960681867 scopus 로고    scopus 로고
    • Low hepcidin accounts for the proinflammatory status associated with iron deficiency
    • Pagani A, Nai A, Corna G, et al. Low hepcidin accounts for the proinflammatory status associated with iron deficiency. Blood. 2011; 118:736–746.
    • (2011) Blood. , vol.118 , pp. 736-746
    • Pagani, A.1    Nai, A.2    Corna, G.3
  • 145
    • 84973130364 scopus 로고    scopus 로고
    • Conference Participants. Iron management in chronic kidney disease: Conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) controversies conference
    • Macdougall IC, Bircher AJ, Eckardt KU, et al. Conference Participants. Iron management in chronic kidney disease: Conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) controversies conference. Kidney Int. 2016; 89:28–39.
    • (2016) Kidney Int. , vol.89 , pp. 28-39
    • Macdougall, I.C.1    Bircher, A.J.2    Eckardt, K.U.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.